BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36891300)

  • 1. The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.
    Lin Z; Mao D; Jin C; Wang J; Lai Y; Zhang Y; Zhou M; Ge Q; Zhang P; Sun Y; Xu K; Wang Y; Zhu H; Lai B; Wu H; Mu Q; Ouyang G; Sheng L
    Front Immunol; 2023; 14():1105293. PubMed ID: 36891300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration analysis of tumor metagenome and peripheral immunity data of diffuse large-B cell lymphoma.
    Zhang Y; Han S; Xiao X; Zheng L; Chen Y; Zhang Z; Gao X; Zhou S; Yu K; Huang L; Fu J; Hong Y; Jiang J; Qian W; Yang H; Shen J
    Front Immunol; 2023; 14():1146861. PubMed ID: 37234150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota in Untreated Diffuse Large B Cell Lymphoma Patients.
    Yuan L; Wang W; Zhang W; Zhang Y; Wei C; Li J; Zhou D
    Front Microbiol; 2021; 12():646361. PubMed ID: 33927704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
    Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
    Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic changes in peripheral blood lymphocyte subset counts and functions in patients with diffuse large B cell lymphoma during chemotherapy.
    Hou H; Luo Y; Tang G; Zhang B; Ouyang R; Wang T; Huang M; Wu S; Li D; Wang F
    Cancer Cell Int; 2021 May; 21(1):282. PubMed ID: 34044841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gut Microbiota and Its Relevance to Peripheral Lymphocyte Subpopulations and Cytokines in Patients with Rheumatoid Arthritis.
    Li Y; Zhang SX; Yin XF; Zhang MX; Qiao J; Xin XH; Chang MJ; Gao C; Li YF; Li XF
    J Immunol Res; 2021; 2021():6665563. PubMed ID: 33506059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of regulatory T cells in blood are a poor prognostic factor in patients with diffuse large B-cell lymphoma.
    Chang C; Wu SY; Kang YW; Lin KP; Chen TY; Medeiros LJ; Chang KC
    Am J Clin Pathol; 2015 Dec; 144(6):935-44. PubMed ID: 26573001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of circulating neutrophils and lymphocyte subsets in newly diagnosed patients with diffuse large B-cell lymphoma.
    Yang Z; Yu W
    Clin Exp Med; 2023 Jul; 23(3):815-822. PubMed ID: 35939174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Impact of Peripheral Blood T-Cell Subsets at the Time of Diagnosis on Survival in Patients with Diffuse Large B-Cell Lymphoma.
    Shin HJ; Kim DY; Chung J; Shin KH; Lee H
    Acta Haematol; 2021; 144(4):427-437. PubMed ID: 33271543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between gut microbiota and lymphocyte subsets in Chinese Han patients with spinal cord injury.
    Pang R; Wang J; Xiong Y; Liu J; Ma X; Gou X; He X; Cheng C; Wang W; Zheng J; Sun M; Bai X; Bai L; Zhang A
    Front Microbiol; 2022; 13():986480. PubMed ID: 36225368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Useful prognostic tools based on complete blood cell counts in diffuse large B-cell lymphoma.
    Shimono J; Takahashi S; Takemura R; Kakinoki Y
    Int J Lab Hematol; 2019 Dec; 41(6):754-761. PubMed ID: 31529774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ratio of Immune Response to Tumor Burden Predicts Survival Via Regulating Functions of Lymphocytes and Monocytes in Diffuse Large B-Cell Lymphoma.
    Ji H; Niu X; Yin L; Wang Y; Huang L; Xuan Q; Li L; Zhang H; Li J; Yang Y; An W; Zhang Q
    Cell Physiol Biochem; 2018; 45(3):951-961. PubMed ID: 29428948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
    Xu-Monette ZY; Li L; Byrd JC; Jabbar KJ; Manyam GC; Maria de Winde C; van den Brand M; Tzankov A; Visco C; Wang J; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Wang M; Hagemeister FB; Piris MA; Han van Krieken J; Medeiros LJ; Li Y; van Spriel AB; Young KH
    Blood; 2016 Dec; 128(26):3083-3100. PubMed ID: 27760757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between CD4
    Lu D; Zhang JB; Wang YX; Geng ST; Zhang Z; Xu Y; Li SY; Wang KH; Kuang YQ
    BMC Infect Dis; 2021 Aug; 21(1):742. PubMed ID: 34344350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
    Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
    Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: results of the PRO-R-IPI study.
    Panizo C; Rodríguez AJ; Gutiérrez G; Díaz FJ; González-Barca E; de Oña R; Grande C; Sancho JM; García-Álvarez MF; Sánchez-González B; Peñalver FJ; Cannata J; Espeso M; Requena MJ; Gardella S; Durán S; González AP; Alfonso A; Caballero MD;
    Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):398-403. PubMed ID: 25843416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infused Autograft Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched Case-Control Study.
    Porrata LF; Burgstaler EA; Winters JL; Jacob E; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Villasboas J; Paludo J; Markovic SN
    Transplant Cell Ther; 2021 Sep; 27(9):769.e1-769.e8. PubMed ID: 34091071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the absolute lymphocyte count/absolute monocyte count ratio, soluble interleukin 2 receptor level, serum programmed cell death 1 level, and the prognosis of patients with diffuse large B-cell lymphoma.
    Li C; Li W; Xu G; You M; Wu W; Kuang L
    Ann Palliat Med; 2021 Oct; 10(10):10938-10945. PubMed ID: 34763456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Level of Blood CD4
    Judd J; Dulaimi E; Li T; Millenson MM; Borghaei H; Smith MR; Al-Saleem T
    Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):83-88. PubMed ID: 28027895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and Clinical Significance of Cytokines and Lymphocyte Subsets in Patients with Diffuse Large B-Cell Lymphoma].
    Xie Y; Bao HY; Shi XF; Wang JN; Han X; Meng QQ; Jiang SY; Zhang L; Zhang LB; Chen WR; Zou XD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):1061-1068. PubMed ID: 37551478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.